EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer With Biparametric Versus Size‐Selective Diffusion MRI

Hao Cheng iD, Jie Lu iD, Ming Liu iD, Wei Zhang iD, Jinxia Zhu iD, Min Chen iD, Dan Wu iD, Chunmei Li iD

Journal of Magnetic Resonance Imaging · 2026-07 · 64 (1) · 55-66

DOI: 10.1002/jmri.70297 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 15.03.2026. Verfasst von Hao Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beij…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Diffusion Magnetic Resonance Imaging, Radiologists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National High Level Hospital Clinical Research Funding, Key Project of Hangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biparametric MRI (bpMRI) was interpreted using Prostate Imaging Reporting and Data System (PI‐RADS) version 2.1, a system associated with relatively low specificity. Selective size imaging using filters via diffusion times MRI (SSIFT‐MRI) is a novel imaging technique that may improve diagnostic performance.

Purpose

To compare the diagnostic performance of bpMRI versus SSIFT‐MRI for diagnosing clinically significant prostate cancer (csPCa). Study Type Prospective. Population Hundred and eighteen men (age: 70 ± 7 years) with suspected csPCa. Field Strength/Sequence Pulsed and oscillating gradient spin‐echo sequences at 3 T. BpMRI included three‐plane T2‐weighted imaging and diffusion‐weighted imaging. Assessment csPCa status was pathologically determined via ultrasound‐guided biopsy or prostatectomy. Three radiologists assessed bpMRI and SSIFT‐MRI for identifying csPCa lesions, and we further compared the performance of combining PI‐RADS with SSIFT‐MRI against that of bpMRI. Statistical Tests Area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for diagnostic performance; bootstrap resampling for comparing AUC; McNemar's test for comparing sensitivity, specificity, PPV, NPV, and accuracy. A p ‐value < 0.05 was considered significant.

Results

Per‐patient accuracy was significantly higher for SSIFT‐MRI (reader 1: 85% vs. 68%; reader 2: 80% vs. 64%; reader 3: 77% vs. 65%). Per‐patient specificity (reader 1: 71% vs. 27%; reader 2: 58% vs. 11%; reader 3: 58% vs. 20%) and PPV (reader 1: 84% vs. 67%; reader 2: 78% vs. 64%; reader 3: 77% vs. 65%) were significantly higher for SSIFT‐MRI. Combining PI‐RADS with SSIFT‐MRI yielded significantly higher AUCs and accuracy than bpMRI alone (AUC and accuracy for reader 1: 0.89% and 83%; reader 2: 0.80% and 73%; reader 3: 0.75% and 72%). Data Conclusion SSIFT‐MRI for csPCa had similar or higher diagnostic performance compared with bpMRI. The combination approach provided significantly higher AUC and accuracy than bpMRI. Evidence Level 1. Stage of Technical Efficacy 2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsDiffusion Magnetic Resonance ImagingRadiologistsHumansMaleAgedProspective StudiesSensitivity and SpecificityReproducibility of ResultsProstateImage Interpretation, Computer-AssistedMiddle AgedROC CurveImage-Guided Biopsy

Stichwörter der Autor:innen

PI‐RADSdiffusion weighted imagingprostate cancer

Autor:innen und Institutionen

  • Department of Radiology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Graduate School of Peking Union Medical College, Beijing, People's Republic of China.
  • Key Laboratory for Biomedical Engineering of Ministry of Education, Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, People's Republic of China.
  • Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Department of Pathology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • MR Research Collaboration, Siemens Healthineers, Beijing, People's Republic of China.

ORCID-Profile: Hao Cheng, Jie Lu, Ming Liu, Wei Zhang, Jinxia Zhu, Min Chen, Dan Wu, Chunmei Li

Förderung

  • National Natural Science Foundation of China
  • National High Level Hospital Clinical Research Funding
  • Key Project of Hangzhou

Zitieren

APA

Cheng, H., Lu, J., Liu, M., Zhang, W., Zhu, J., Chen, M., Wu, D., & Li, C. (2026). Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer With Biparametric Versus Size‐Selective Diffusion MRI. Journal of Magnetic Resonance Imaging, 64(1), 55-66. https://doi.org/10.1002/jmri.70297

Vancouver

Cheng H, Lu J, Liu M, Zhang W, Zhu J, Chen M, et al. Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer With Biparametric Versus Size‐Selective Diffusion MRI. Journal of Magnetic Resonance Imaging. 2026;64(1):55-66. doi:10.1002/jmri.70297

BibTeX
@article{Cheng2026,
  author = {Cheng, Hao and Lu, Jie and Liu, Ming and Zhang, Wei and Zhu, Jinxia and Chen, Min and Wu, Dan and Li, Chunmei},
  title = {Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer With Biparametric Versus Size‐Selective Diffusion MRI},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2026},
  volume = {64},
  number = {1},
  pages = {55--66},
  doi = {10.1002/jmri.70297}
}
Kostenlos starten →